Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 184

  • The following term was not found in PubMed: Sperry-Taylor.
1.

In vitro activity and microbiological efficacy of gepotidacin from a phase 2, randomized, multicenter, dose-ranging study in patients with acute bacterial skin and skin structure infections.

Scangarella-Oman NE, Ingraham KA, Tiffany CA, Tomsho L, Van Horn SF, Mayhew DN, Perry CR, Ashton TC, Dumont EF, Huang J, Brown JR, Miller LA.

Antimicrob Agents Chemother. 2019 Dec 9. pii: AAC.01302-19. doi: 10.1128/AAC.01302-19. [Epub ahead of print]

2.

Demonstration of the Use of Environmental DNA for the Non-Invasive Genotyping of a Bivalve Mollusk, the European Flat Oyster (Ostrea edulis).

Holman LE, Hollenbeck CM, Ashton TJ, Johnston IA.

Front Genet. 2019 Nov 19;10:1159. doi: 10.3389/fgene.2019.01159. eCollection 2019.

3.

The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.

Ashton TD, Devine SM, Möhrle JJ, Laleu B, Burrows JN, Charman SA, Creek DJ, Sleebs BE.

J Med Chem. 2019 Dec 12;62(23):10526-10562. doi: 10.1021/acs.jmedchem.9b00761. Epub 2019 Aug 20.

PMID:
31385706
4.

New Zealand health system: universalism struggles with persisting inequities.

Goodyear-Smith F, Ashton T.

Lancet. 2019 Aug 3;394(10196):432-442. doi: 10.1016/S0140-6736(19)31238-3. Review.

PMID:
31379334
5.

Early herpes and TTV DNAemia in septic shock patients: a pilot study.

Mallet F, Perret M, Tran T, Meunier B, Guichard A, Tabone O, Mommert M, Brengel-Pesce K, Venet F, Pachot A, Monneret G, Reynier F, Védrine C, Leissner P, Moucadel V, Lepape A, Textoris J; MIPrea group; REALISM group.

Intensive Care Med Exp. 2019 May 18;7(1):28. doi: 10.1186/s40635-019-0256-z.

6.

Tailoring the electrochemical activity of magnesium chromium oxide towards Mg batteries through control of size and crystal structure.

Hu L, Johnson ID, Kim S, Nolis GM, Freeland JW, Yoo HD, Fister TT, McCafferty L, Ashton TE, Darr JA, Cabana J.

Nanoscale. 2019 Jan 3;11(2):639-646. doi: 10.1039/c8nr08347a.

PMID:
30564812
7.

Evaluation of 4-Amino 2-Anilinoquinazolines against Plasmodium and Other Apicomplexan Parasites In Vitro and in a P. falciparum Humanized NOD-scid IL2Rγnull Mouse Model of Malaria.

Gilson PR, Nguyen W, Poole WA, Teixeira JE, Thompson JK, Guo K, Stewart RJ, Ashton TD, White KL, Sanz LM, Gamo FJ, Charman SA, Wittlin S, Duffy J, Tonkin CJ, Tham WH, Crabb BS, Cooke BM, Huston CD, Cowman AF, Sleebs BE.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01804-18. doi: 10.1128/AAC.01804-18. Print 2019 Mar.

8.

Highly fluorescent and HDAC6 selective scriptaid analogues.

Fleming CL, Natoli A, Schreuders J, Devlin M, Yoganantharajah P, Gibert Y, Leslie KG, New EJ, Ashton TD, Pfeffer FM.

Eur J Med Chem. 2019 Jan 15;162:321-333. doi: 10.1016/j.ejmech.2018.11.020. Epub 2018 Nov 9.

PMID:
30448419
9.

T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.

Herbert KJ, Ashton TM, Prevo R, Pirovano G, Higgins GS.

Cell Death Dis. 2018 Oct 24;9(11):1089. doi: 10.1038/s41419-018-1131-7. Review.

10.

Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane.

Hickey SM, Ashton TD, Boer G, Bader CA, Thomas M, Elliott AG, Schmuck C, Yu HY, Li J, Nation RL, Cooper MA, Plush SE, Brooks DA, Pfeffer FM.

Eur J Med Chem. 2018 Dec 5;160:9-22. doi: 10.1016/j.ejmech.2018.09.072. Epub 2018 Oct 3.

11.

A Research Program on Implementing Integrated Care for Older Adults with Complex Health Needs (iCOACH): An International Collaboration.

Wodchis WP, Ashton T, Baker GR, Sheridan N, Kuluski K, McKillop A, Miller FA, Parsons J, Kenealy T; iCOACH study team.

Int J Integr Care. 2018 May 9;18(2):11. doi: 10.5334/ijic.4160.

12.

Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net.

de Kraker MEA, Sommer H, de Velde F, Gravestock I, Weiss E, McAleenan A, Nikolakopoulos S, Amit O, Ashton T, Beyersmann J, Held L, Lovering AM, MacGowan AP, Mouton JW, Timsit JF, Wilson D, Wolkewitz M, Bettiol E, Dane A, Harbarth S; COMBACTE-NET Consortium.

Clin Infect Dis. 2018 Nov 28;67(12):1922-1931. doi: 10.1093/cid/ciy516.

13.

Mechanistic insights of Li+ diffusion within doped LiFePO4 from Muon Spectroscopy.

Johnson ID, Ashton TE, Blagovidova E, Smales GJ, Lübke M, Baker PJ, Corr SA, Darr JA.

Sci Rep. 2018 Mar 7;8(1):4114. doi: 10.1038/s41598-018-22435-1.

14.

Oxidative Phosphorylation as an Emerging Target in Cancer Therapy.

Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS.

Clin Cancer Res. 2018 Jun 1;24(11):2482-2490. doi: 10.1158/1078-0432.CCR-17-3070. Epub 2018 Feb 2. Review.

15.

APCVD hexagonal boron nitride thin films for passive near-junction thermal management of electronics.

Kc P, Rai A, Ashton TS, Moore AL.

Nanotechnology. 2017 Dec 15;28(50):505705. doi: 10.1088/1361-6528/aa97ae.

PMID:
29095146
16.

Modular synthesis of 4-aminocarbonyl substituted 1,8-naphthalimides and application in single molecule fluorescence detection.

Hearn KN, Nalder TD, Cox RP, Maynard HD, Bell TDM, Pfeffer FM, Ashton TD.

Chem Commun (Camb). 2017 Nov 14;53(91):12298-12301. doi: 10.1039/c7cc07922b.

PMID:
29094133
17.

How do Policy and Institutional Settings Shape Opportunities for Community-Based Primary Health Care? A Comparison of Ontario, Québec and New Zealand.

Tenbensel T, Miller F, Breton M, Couturier Y, Morton-Chang F, Ashton T, Sheridan N, Peckham A, Williams AP, Kenealy T, Wodchis W.

Int J Integr Care. 2017 Jun 27;17(2):13. doi: 10.5334/ijic.2514.

18.

Productivity of public hospitals in Nepal: a data envelopment analysis.

Silwal PR, Ashton T.

BMJ Open. 2017 Jul 20;7(7):e015327. doi: 10.1136/bmjopen-2016-015327.

19.

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy.

Pirovano G, Ashton TM, Herbert KJ, Bryant RJ, Verrill CL, Cerundolo L, Buffa FM, Prevo R, Harrap I, Ryan AJ, Macaulay V, McKenna WG, Higgins GS.

Br J Cancer. 2017 Aug 8;117(4):503-512. doi: 10.1038/bjc.2017.197. Epub 2017 Jul 4.

20.

The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients.

Rol ML, Venet F, Rimmele T, Moucadel V, Cortez P, Quemeneur L, Gardiner D, Griffiths A, Pachot A, Textoris J, Monneret G; REALISM study group.

BMJ Open. 2017 Jun 21;7(6):e015734. doi: 10.1136/bmjopen-2016-015734.

Supplemental Content

Loading ...
Support Center